Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size
CONSENSUS STATEMENT
Year : 2021  |  Volume : 16  |  Issue : 2  |  Page : 188-218

Application of aerosol therapy in respiratory diseases in children: A Saudi expert consensus


1 Department of Pediatrics, Prince Sultan Military City, Ministry of Defence, Riyadh, Saudi Arabia
2 Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam; Department of Pediatrics, King Fahd Hospital of the University, Khobar, Saudi Arabia
3 Department of Pediatrics, Umm Al-Qura University, Mecca; Department of Pediatrics, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
4 Department of Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
5 Department of Pediatrics, King Fahad Specialist Hospital, Dammam, Saudi Arabia
6 Department of Emergency, Pediatric Emergency Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia
7 Department of Pediatrics, Umm Al Qura University, Makkah; Department of Pediatrics, International Medical Center, Jeddah, Saudi Arabia
8 Department of Respiratory Therapy Sciences, Inaya Medical College, Riyadh, Saudi Arabia
9 Department of Pediatrics, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

Correspondence Address:
Prof. Adel S Alharbi
Department of Paediatrics, Prince Sultan Military Medical City, Riyadh
Saudi Arabia
Login to access the Email id


DOI: 10.4103/atm.atm_74_21

Rights and Permissions

The Saudi Pediatric Pulmonology Association (SPPA) is a subsidiary of the Saudi Thoracic Society (STS), which consists of a group of Saudi experts with well-respected academic and clinical backgrounds in the fields of asthma and other respiratory diseases. The SPPA Expert Panel realized the need to draw up a clear, simple to understand, and easy to use guidance regarding the application of different aerosol therapies in respiratory diseases in children, due to the high prevalence and high economic burden of these diseases in Saudi Arabia. This statement was developed based on the available literature, new evidence, and experts' practice to come up with such consensuses about the usage of different aerosol therapies for the management of respiratory diseases in children (asthma and nonasthma) in different patient settings, including outpatient, emergency room, intensive care unit, and inpatient settings. For this purpose, SPPA has initiated and formed a national committee which consists of experts from concerned specialties (pediatric pulmonology, pediatric emergency, clinical pharmacology, pediatric respiratory therapy, as well as pediatric and neonatal intensive care). These committee members are from different healthcare sectors in Saudi Arabia (Ministry of Health, Ministry of Defence, Ministry of Education, and private healthcare sector). In addition to that, this committee is representing different regions in Saudi Arabia (Eastern, Central, and Western region). The subject was divided into several topics which were then assigned to at least two experts. The authors searched the literature according to their own strategies without central literature review. To achieve consensus, draft reports and recommendations were reviewed and voted on by the whole panel.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed680    
    Printed18    
    Emailed0    
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal